1. Rücker, G., Schumacher, M.: Simpson’s paradox visualized: The example of the Rosiglitazone meta-analysis. BMC Med. Res. Methodol. 8, 34 (2008)
2. MF Drummond, MJ Sculpher, K Claxton, GL Stoddart, and GW Torrance. Methods for the economic evaluation of health care programmes. Fourth Edition. Oxford University Press (2015)
3. MR Gold, JE Siegel, LB Russell, and MC Weinstein, editors. Cost-effectiveness in health and medicine. Oxford University Press (1996)
4. Kennedy-Martin, M., Slaap, B., Herdman, M., van Reenen, M., Kennedy-Martin, T., Greiner, W., Busschbach, J., Boye, K.S.: Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines. Eur. J. Health Econ. 21, 1245–1257 (2020)
5. Torrance, G.W., Thomas, W.H., Sackett, D.L.: A utility maximization model for evaluation of health care programs. Health Serv. Res 7, 118–133 (1972)